Leo sues Perrigo for patent infringement over skin gel
14-06-2016
Teva gets under Leo’s skin, knocks out two patents
06-10-2014
NicoElnino / iStockphoto.com
Denmark-based Leo Pharma and Californian rare disease company PellePharm have partnered to develop and commercialise therapies for rare forms of skin cancer.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Leo Pharma, PellePharm, collaboration, rare diseases, topical gel, Gorlin Syndrome, skin cancer, oncology,
